UC Davis CTSC Clinical Research Center (CCRC) at Veterans Affair Medical Center
Mather, California, 95655, United States
NCT Number: NCT00853775
The purpose of this study is to determine whether lipoprotein(a), also called Lp(a), is a risk factor for cardiovascular (heart) disease. Lipoproteins are tiny particles that circulate in the blood. They contain cholesterol, fat, and protein in varying amounts depending on the body's need. Higher levels of lipoproteins in the blood can cause an increased risk of heart disease.
The investigators believe that by studying the Lp(a) lipoprotein in Caucasians and African Americans, the investigators can assess for genetic variation factors related to cardiovascular (heart) disease. The investigators will be looking at 100 African-American families and 100 Caucasian families to confirm whether a higher Lp(a) level is an indicator of a higher risk for heart disease.
Looking for future studies?
Notify Me6 year and older
All sexes
Observational
Mather, California, 95655, United States
During the study visit the research staff will ask about the medical history, perform a brief physical exam, and draw approximately 4 teaspoons of blood of each family member.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: five years
University of California, Davis
Other
Regulation of Lipoprotein(a) Metabolism in Humans With Reference to Ethnicity
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01399385
Arterial Occlusive Diseases, Arteriosclerosis
Bethesda, Maryland, United States
View Trial DetailsNCT06896773
Cardiovascular Diseases, Healthy
Warsaw, Masovian Voivodeship, Poland
View Trial DetailsNCT06318390
Cardiovascular Diseases, Cognition Disorders
Arlington, Texas, United States
View Trial DetailsNCT05987891
Cardiovascular Abnormalities, Cardiovascular Diseases
São Paulo, Brazil
View Trial Details